Introduction
the electronic Hospital Information System (HIS) at the three county-level hospitals. 138 We manually reviewed the paper-based medical charts at the three township hospitals. 139 We did not visit the other 20 township hospitals to collect the number of HFMD- A multiplier model [28] was used to estimate the hospitalization rates of HFMD in 146 this study (Fig 1) . We divided the patients and the population denominators into eight 147 age groups, including <6 months, 6-11 months, 12-23 months, 24-35 months, 36-47 9 148 months, 48-59 months, 5-9 years, and 10-14 years. We assumed that the age stratified 149 admission rates were comparable among the township level hospitals. We extrapolated 150 the number of HFMD-associated hospitalizations per age group among 23 township 151 level hospitals based on data from the three township hospitals and number of total 152 hospitalizations among all township level hospitals (Fig 1) . The total number of 153 hospitalizations for HFMD in each age group in Anhua county was the sum of the Anhua County. We assumed that the age-specific distribution of enterovirus serotype 160 in the enrolled group was the same as that in the non-enrolled group (Fig 1) . for Disease Control and Prevention (no. 201224) . This study was considered to be part Therefore, written informed consents were not obtained from subjects. The IRB 181 approved the use of verbal consent, and agreed that we anonymized the specimens and 182 personal information by permanently removing personal identifiers from the database.
183
Anonymized samples were labeled with a random coding system. Verbal informed 184 consent was obtained form the patients' parents/guardians when sampling and filling 185 out the questionnaire, and documented in forms.
187

Results
188
Virological surveillance 189 During the three-year virological surveillance, 2,836 (85%) of the total of 3,326 190 hospitalized patients with a diagnosis of HFMD were enrolled across the six hospitals.
191
The baseline characteristics were similar between the enrolled and un-enrolled patients, 11 192 including gender, age, and length of hospital stay [26] . One 27-month old child with 193 detection of EV-A71 had symptoms of neurological involvement (frequent jittering and 194 myoclonic jerks after 4 days of fever), and all others had uncomplicated illnesses.
195
Enterovirus was detected among 2,517 (89%) patients via the real-time targeting pan-enterovirus. Nineteen serotypes of enterovirus were successfully 197 identified in 2,513 (99.8%) patients. The most commonly detected were CV-A16 (33%, 198 819), CV-A6 (31%, 785), EV-A71 (20%, 514), and CV-A10 (6%, 149). CV-A6 199 infections were more frequently identified in patients younger than 2 years, while CV-
200
A16 and EV-A71 accounted for a higher proportion of HFMD among children aged ≥3 201 years than CV-A6 (p<0.001) (S1 Table) . A seasonal peak in total hospitalizations 202 associated with HFMD was observed between April and June (S1 Fig) . Table) . Among these, 3,236 (89%) patients were 208 estimated to be positive for enterovirus. The mean hospitalization rates of probable 209 HFMD were estimated as 743 (95% CI: 719-768) per 100,000 person-years, and the 210 mean rates of lab-confirmed HFMD were 660 (95% CI: 638-684) hospitalizations per 211 100,000 person-years during the surveillance period (Fig 2A) . Both the annual 212 hospitalization rates of probable and lab-confirmed HFMD were highest during the 213 2013-2014 season (1,099 and 1,011 per 100,000 person-years), and lowest during the 12 214 2014-2015 season (458 and 422 per 100,000 person-years) ( Fig 2B) . infections (p<0.001) (Fig 2A) .
230
In the first year, between October 2013 and September 2014, the hospitalization 231 rates for CV-A16 were the highest (467 per 100,000 person-years). While in the second 232 year, CV-A6 had the largest burden of hospitalizations (248 per 100,000 person-years).
233
The hospitalization rates were similar among CV-A16, CV-A6, and EV-A71 infections 234 in the third year (p=0.568) ( Fig 2B) . The annual hospitalizations varied substantially 235 over years for EV-A71, CV-A16, and CV-A10. However, CV-A6 displayed 13 236 comparable hospitalization rates over three years ( Fig 2B) .
237
Age-specific hospitalization rates of HFMD 238 The mean hospitalization rates of HFMD varied with age. The highest rates of lab-239 confirmed HFMD were among children aged 12-23 months (3,594 per 100,000 person-240 years), followed by 24-35 months (1,828 per 100,000 person-years) and then 6-11 241 months (1,572 per 100,000 person-years). The hospitalization rates were lower among 242 infants younger than 6 months (381 per 100,000 person-years) and among children aged 243 5-14 years (84 per 100,000 person-years) ( Fig 3B) . Similar age distributions of 244 hospitalization rates were observed for probable HFMD (Fig 3A) . The mean rates of 245 probable and lab-confirmed HFMD were 1,829 and 1,638 hospitalizations per 100,000 246 person-years (respectively) among children younger than 5 years. Unlike the 247 distribution of yearly rates for children aged ≥12 months, the hospitalization rates 248 decreased over three years for children aged 0-11 months (Fig 3C and D) . The four common enterovirus serotypes had highest hospitalization rates among 14 258 children aged 12-23 months (955 for CV-A16, 1,344 for CV-A6, 640 for EV-A71, and 259 267 for CV-A10 per 100,000 person-years) (Fig 4A-D) . CV-A6 uniquely had higher 260 rates among children aged 6-11 months than among those aged 24-35 months (p<0.001), 261 while CV-A10 had comparable rates between these age groups (p=0.849) (Fig 4A-D) . 262 Statistical analyses suggested that HFMD hospitalization associated with CV-A6 were 263 evident at younger ages, compared to EV-A71 and CV-A16. The distribution pattern 264 of age-specific hospitalization rates for CV-A16, EV-A71, and CV-A10 were 265 consistent across the three years, between October 2013 to September 2016 (S2 Fig) .
266
For CV-A6, the higher hospitalization rates in 6-11 months than 24-35 months was not serotype.
303
In our study, all children with mild illness (except one) were admitted to hospital.
304
The reasons underlying overuse of healthcare resources for mild illnesses include a low 99% among HFMD-associated hospitalizations in previous reports [21, 24, 25, 29] . The 310 patients without complications were hospitalized in these reports because of high fever, 311 poor feeding, mouth ulcers, vomiting, or dehydration [24] . This indicates that 312 hospitalizations for non-severe HFMD is common in China.
313
To our knowledge, population-based hospitalization rates for HFMD have not been 314 reported until now. As the threshold for hospitalization of HFMD in our study was 315 relatively low, we made comparisons with the incidence rates estimated using the 316 notifiable surveillance data [2, [17] [18] [19] [20] . The hospitalization rates estimated in our study 317 (119/100,000 person-years) were comparable to the incidence rates reported in 318 mainland China during 2008-2015 (127/100,000 person-years) [2, 20] . The rates we 319 estimated were higher than the incidence rates in Malaysia during 2011-2014 (20-320 90/100,000 person-years) [19] , and lower than the incidence rates in Singapore during Outpatients were not included in our study, therefore the hospitalization rates we report 331 could be an underestimate of the true incidence rates in Anhua County.
332
The age pattern of HFMD-associated hospitalizations was consistent with previous 333 reports of HFMD-associated incidences [2, 19, 20] . Relatively low hospitalization rates 334 among children younger than 6 months were likely due to protection by maternal 335 antibodies [32] . Compared to older children who may attend kindergartens or nurseries, 336 children aged 6-23 months have a lower intensity of contact with those of similar ages 337 due to limited mobility. The high hospitalization rates among this age group may 338 suggest higher susceptibility and/or possible transmission routes from contact with 339 asymptomatic adults or contaminated environments [20] . Serological surveillance also 340 revealed a low level of sero-prevalence in children aged 6-23 months [32, 33] . 341 Our study found that CV-A6 presented a higher burden of HFMD-associated 342 hospitalization than EV-A71. This was consistent with the increasing activity of CV-343 A6 in China [10, 11, [34] [35] [36] and the regional introduction of CV-A6 in 2012. CV-A6-344 associated hospitalizations were also higher among younger age groups than EV-A71 345 and CV-A16 [37] [38] [39] . This may result from lower maternal immunity against an 18 346 emerging virus. As observed in this study, CV-A6 will likely affect more older children 347 and present a similar age pattern to EV-A71 and CV-A16, since more maternal 348 immunity is attained after introduction and spread of CV-A6, causing the median age We found a substantial hospitalization burden annually for mild HFMD, caused by 369 multiple enterovirus serotypes in China. During the study period, CV-A16 and CV-A6
